Antidote removal during haemodialysis for massive acetaminophen overdose

Clinical Toxicology

Volumn 51, Issue 9, 2013, Pages 855-863

  Sivilotti, M L A ^a,b   Juurlink, D N ^b,c,d   Garland, J S ^a   Lenga, I ^c   Poley, R ^a   Hanly, L N ^e   Thompson, M ^b,c  

^a QUEEN S UNIVERSITY   (Canada)

^b Ontario Poison Centre   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Acetaminophen; Haemodialysis; Mitochondria; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; ANTIDOTE; LACTIC ACID; PARACETAMOL;

ACIDEMIA; ADULT; AGED; ARTICLE; CASE REPORT; COMATOSE PATIENT; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG OVERDOSE; FEMALE; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; HYPOTHERMIA; LACTIC ACIDOSIS; LOADING DRUG DOSE; MALE;

ACETAMINOPHEN; ACETYLCYSTEINE; ACIDOSIS, LACTIC; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANTIDOTES; COMA; DRUG MONITORING; DRUG OVERDOSE; FEMALE; FREE RADICAL SCAVENGERS; HALF-LIFE; HUMANS; LIVER FAILURE; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; RENAL DIALYSIS; YOUNG ADULT;

EID: 84886604852     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2013.844824     Document Type: Article

References (72)

1. Farid NR, Glynn JP, Kerr DNS. Haemodialysis in paracetamol selfpoisoning. Lancet 1972; 300: 396-398.
2. Matthew H, Gibson PF, Kerr DNS. Haemodialysis in paracetamol self-poisoning. Lancet 1972; 300: 607.
3. Prescott LF. Haemodialysis in paracetomol self-poisoning. Lancet 1972; 2: 652.
4. Matthew H. Acute acetaminophen poisoning. Clin Toxicol 1973 ; 6: 9-11.
5. Winchester JF, Gelfand MC, Helliwell M, Vale JA, Goulding R, Schreiner GE. Extracorporeal treatment of salicylate or acetaminophen poisoning-is there a role? Arch Intern Med 1981; 141: 370-374.
6. Lieh-Lai MW, Sarnaik AP, Newton JF, Miceli JN, Fleischmann LE, Hook JB, Kauffman RE. Metabolism and pharmacokinetics of acetaminophen in a severely poisoned young child. J Pediatr 1984 ; 105: 125-128.
7. Holubek WJ, Hoffman RS, Goldfarb DS, Nelson LS. Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int 2008; 74: 1327-1334.
8. Tyagi PK, Winchester JF, Feinfeld DA. Extracorporeal removal of toxins. Kidney Int 2008; 74: 1231-1233.
9. Donovan JW, Burkhart KK, O Donnell S, Shaer A. Hemodialysis for acetaminophen-induced acute liver failure (abstract). Clin Toxicol 2005; 43: 433.
10. S hah A D, W ood D M, D argan P I. U nderstanding lactic acidosis in paracetamol (acetaminophen) poisoning. Br J Clin Pharmacol 2011 ; 71: 20-28.
11. W iegand T J, M argaretten M, O lson K R. M assive acetaminophen ingestion with early metabolic acidosis and coma: Treatment with IV NAC and continuous venovenous hemodiafi ltration. Clin Toxicol 2010; 48: 156-159.
12. Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT. The disposition and kinetics of intravenous N-Acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989; 37: 501-506.
13. Brown M, Bjorksten A, Medved I, McKenna M. Pharmacokinetics of intravenous N-Acetylcysteine in men at rest and during exercise. Eur J Clin Pharmacol 2004; 60: 717-723.
14. Jones AL, Jarvie DR, Simpson D, Hayes PC, Prescott LF. Pharmacokinetics of N-Acetylcysteine are altered in patients with chronic liver disease. Aliment Pharmacol Ther 1997; 11: 787-791.
15. Borgstrom L, Kagedal B, Paulsen O. Pharmacokinetics of N-Acetylcysteine in man. Eur J Clin Pharmacol 1986; 31: 217-222.
16. De Caro L, Ghizzi A, Costa R, Longo A, Ventresca GP, Lodola E. Pharmacokinetics and bioavailability of oral acetylcysteine in healthy volunteers. Arzneimittelforschung 1989; 39: 382-386.
17. Holdiness MR. Clinical Pharmacokinetics of N-Acetylcysteine. Clin Pharmacokinet 1991; 20: 123-134.
18. Zezulka A, Wright N. Severe metabolic acidosis early in paracetamol poisoning. Br Med J Clin Res Ed 1982; 285: 851-852.
19. Vale JA, Meredith TJ. Metabolic acidosis in paracetamol poisoning. BMJ 1982; 285: 1208.
20. Dunn RJ. Massive sulfasalazine and paracetamol ingestion causing acidosis, hyperglycemia, coagulopathy, and methemoglobinemia. J Toxicol Clin Toxicol 1998; 36: 239-242.
21. Roth B, Woo O, Blanc P. Early metabolic acidosis and coma after acetaminophen ingestion. Ann Emerg Med 1999; 33: 452-456.
22. Steelman R, Goodman A, Biswas S, Zimmerman A. Metabolic acidosis and coma in a child with acetaminophen toxicity. Clin Pediatr (Phila) 2004; 43: 201-203.
23. Ala A, Schiano T, Burroughs A, Keshav S. Recognition of nonhepatic coma in the setting of acetaminophen overdose. Dig Dis Sci 2004 ; 49: 1977-1980.
24. Mendoza CD, Heard K, Dart RC. Coma, metabolic acidosis and normal liver function in a child with a large serum acetaminophen level. Ann Emerg Med 2006; 48: 637.
25. O Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989 ; 97: 439-445.
26. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: A cohort study. Lancet 2002; 359: 558-563.
27. Z ell-Kanter M, C oleman P, W hiteley P M, L eikin J B. A gargantuan acetaminophen level in an acidemic patient treated solely with intravenous N-Acetylcysteine. Am J Ther 2013; 20: 104-106.
28. Esterline RL, Ji S. Metabolic alterations resulting from the inhibition of mitochondrial respiration by acetaminophen in vivo. Biochem Pharmacol 1989; 38: 2390-2392.
29. Esterline RL, Ray SD, Ji S. Reversible and irreversible inhibition of hepatic mitochondrial respiration by acetaminophen and its toxic metabolite, N-Acetyl-p-benzoquinoneimine (NAPQI). Biochem Pharmacol 1989; 38: 2387-2390.
30. Massey TE, Walker RM, McElligott TF, Racz WJ. Acetaminopheninduced hypothermia in mice: Evidence for a central action of the parent compound. Toxicology 1982; 25: 187-200.
31. Gray TA, Buckley BM, Vale JA. Hyperlactataemia and metabolic acidosis following paracetamol overdose. Q J Med 1987; 65 : 811-821.
32. Jacobsen DW, Gatautis VJ, Green R, Robinson K, Savon SR, Secic M, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem 1994; 40: 873-881.
33. Soldini D, Zwahlen H, Gabutti L, Marzo A, Marone C. Pharmacokinetics of N-Acetylcysteine following repeated intravenous infusion in haemodialysed patients. Eur J Clin Pharmacol 2005 ; 60: 859-864.
34. Smilkstein MJ, Bronstein AC, Linden C, Augenstein WL, Kulig KW, Rumack BH. Acetaminophen overdose: A 48-hour intravenous N-Acetylcysteine treatment protocol. Ann Emerg Med 1991; 20: 1058-1063.
35. Koulouris Z, Tierney MG, Jones G. Metabolic acidosis and coma following a severe acetaminophen overdose. Ann Pharmacother 1999; 33: 1191-1194.
36. F lanagan R J, M ant T G. C oma and metabolic acidosis early in severe acute paracetamol poisoning. Hum Toxicol 1986; 5: 179-182.
37. Pond SM, Tong TG, Kaysen GA, Menke DJ, Galinsky RE, Roberts SM, Levy G. Massive intoxication with acetaminophen and propoxyphene: Unexpected survival and unusual pharmacokinetics of acetaminophen. J Toxicol Clin Toxicol 1982; 19: 1-16.
38. Sivilotti ML, Green TJ, Langmann C, Yarema M, Juurlink D, Johnson D. Multiplying the serum aminotransferase by the acetaminophen concentration to predict toxicity following overdose. Clin Toxicol 2010; 48: 793-799.
39. Sivilotti MLA, Yarema MC, Juurlink DN, Good AM, Johnson DW. A risk quantifi cation instrument for acute acetaminophen overdose patients treated with N -Acetylcysteine. Ann Emerg Med 2005 ; 45: 263-271.
40. Olsson B, Johansson M, Gabrielsson J, Bolme P. Pharmacokinetics and bioavailability of reduced and oxidized N-Acetylcysteine. Eur J Clin Pharmacol 1988; 34: 77-82.
41. Selden BS, Curry SC, Clark RF, Johnson BC, Meinhart R, Pizziconi VB. Transplacental transport of N-Acetylcysteine in an ovine model. Ann Emerg Med 1991; 20: 1069-1072.
42. Pakravan N, Waring WS, Sharma S, Ludlam C, Megson I, Bateman DN. Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. Clin Toxicol 2008 ; 46: 697-702.
43. A hola T, F ellman V, L aaksonen R, L aitila J, L apatto R, N euvonen P J, Raivio KO. Pharmacokinetics of intravenous N-Acetylcysteine in pre-Term new-born infants. Eur J Clin Pharmacol 1999; 55 : 645-650.
44. Rumack BH, Bateman DN. Acetaminophen and acetylcysteine dose and duration: Past, present and future. Clin Toxicol 2012; 50 : 91-98.
45. Rumack BH. Acetaminophen hepatotoxicity: The fi rst 35 years. Clin Toxicol 2002; 40: 3-20.
46. Heard K, Schaeffer TH. Massive acetylcysteine overdose associated with cerebral edema and seizures. Clin Toxicol 2011; 49: 423-425.
47. Bailey B, Blais R, Letarte A. Status epilepticus after a massive intravenous N-Acetylcysteine overdose leading to intracranial hypertension and death. Ann Emerg Med 2004; 44: 401-406.
48. Ferner RE, Langford NJ, Anton C, Hutchings A, Bateman DN, Routledge PA. Random and systematic medication errors in routine clinical practice: A multicentre study of infusions, using acetylcysteine as an example. Br J Clin Pharmacol 2001; 52: 573-577.
49. Hayes BD, Klein-Schwartz W, Doyon S. Frequency of medication errors with intravenous acetylcysteine for acetaminophen overdose. Ann Pharmacother 2008; 42: 766-770.
50. Johnson MT, McCammon CA, Mullins ME, Halcomb SE. Evaluation of a simplifi ed N-Acetylcysteine dosing regimen for the treatment of acetaminophen toxicity (June). Ann Pharmacother 2011; 45 : 713-720.
51. Shen F, Coulter CV, Isbister GK, Duffull SB. A dosing regimen for immediate N-Acetylcysteine treatment for acute paracetamol overdose. Clin Toxicol 2011; 49: 643-647.
52. Klein-Schwartz W, Doyon S. Intravenous acetylcysteine for the treatment of acetaminophen overdose. Expert Opin Pharmacother 2011; 12: 119-130.
53. Schiodt FV, Clemmesen JO, Hansen BA, Larsen FS. Cerebral edema due to hemodialysis in paracetamol-induced fulminant hepatic failure. Scand J Gastroenterol 1995; 30: 927-928.
54. Steadman RH, Van Rensburg A, Kramer DJ. Transplantation for acute liver failure: Perioperative management. Curr Opin Organ Transplant 2010; 15: 368-373.
55. Lavergne V, Nolin TD, Hoffman RS, Roberts D, Gosselin S, Goldfarb DS, et al. The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: Guideline methodology. Clin Toxicol 2012 ; 50: 403-413.
56. Porter KE, Dawson AG. Inhibition of respiration and gluconeogenesis by paracetamol in rat kidney preparations. Biochem Pharmacol 1979 ; 28: 3057-3062.
57. Truitt CA, Curry SC, Canning JE, French R. Large APAP OD with fi xed pupils, optic pallor, massive lactic acidosis, elevated lactate/ pyruvate ratio, and hyperalaninemia with full recovery and minimal hypertransaminasemia (abstract). Clin Toxicol 2010; 48: 610.
58. Fannin RD, Russo M, O Connell TM, Gerrish K, Winnike JH, Macdonald J, et al. Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation. Hepatology 2010; 51: 227-236.
59. Zein JG, Wallace DJ, Kinasewitz G, Toubia N, Kakoulas C. Early anion gap metabolic acidosis in acetaminophen overdose. Am J Emerg Med 2010; 28: 798-802.
60. Green TJ, Bijlsma JJ, Sweet DD. Profound metabolic acidosis from pyroglutamic acidemia: An underappreciated cause of high anion gap metabolic acidosis. Can J Emerg Med 2010; 12: 449-452.
61. Zand L, Muriithi A, Nelsen E, Franco PM, Greene EL, Qian Q, El-Zoghby ZM. Severe anion gap metabolic acidosis from acetaminophen use secondary to 5-oxoproline (pyroglutamic acid) accumulation. Am J Med Sci 2012; 344: 501-504.
62. R eddi A S, K unadi A R. R ecurrent anion gap metabolic acidosis in a woman with vertebral disc disease. Am J Emerg Med 2011 ; 29: 962. e3-e8.
63. Prescott LF, Roscoe P, Wright N, Brown SS. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet 1971; 1: 519-522.
64. Schiodt FV, Ott P, Christensen E, Bondesen S. The value of plasma acetaminophen half-life in antidote-Treated acetaminophen overdosage. Clin Pharmacol Ther 2002; 71: 221-225.
65. Saiao A, Chan B, Isbister GK. Pharmacokinetics and outcomes in massive paracetamol overdose (abstract). Clin Toxicol 2012; 50: 276.
66. Forrest JA, Roscoe P, Prescott LF, Stevenson IH. Abnormal drug metabolism after barbiturate and paracetamol overdose. Br Med J 1974; 4: 499-502.
67. Graudins A, Chiew A, Chan B. Overdose with modifi ed-release paracetamol results in delayed and prolonged absorption of paracetamol. Intern Med J 2010; 40: 72-76.
68. Smith SW, Howland MA, Hoffman RS, Nelson LS. Acetaminophen overdose with altered acetaminophen pharmacokinetics and hepatotoxicity associated with premature cessation of intravenous N-Acetylcysteine therapy. Ann Pharmacother 2008; 42 : 1333-1339.
69. Doyon S, Klein-Schwartz W. Hepatotoxicity despite early administration of intravenous N-Acetylcysteine for acute acetaminophen overdose. Acad Emerg Med 2009; 16: 34-39.
70. Schwartz EA, Hayes BD, Sarmiento KF. Development of hepatic failure despite use of intravenous acetylcysteine after a massive ingestion of acetaminophen and diphenhydramine. Ann Emerg Med 2009; 54: 421-423.
71. Bihari S, Verghese S, Bersten AD. Delayed and prolonged elevated serum paracetamol level after an overdose-possible causes and implications. Crit Care Resusc 2011; 13: 275-277.
72. Rumack BH, Meredith TJ, Peterson RG, Prescott LF, Vale JA. Panel discussion. Management of acetaminophen overdose. Arch Intern Med 1981; 141: 3.